Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
about
PPARs and the cardiovascular systemThe NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationTranscriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell functionDownregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposisVascular targets for cannabinoids: animal and human studiesPPAR-γ -- a possible drug target for complicated pregnanciesPPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyRosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cellsDrugs for cardiovascular risk reduction in the diabetic patientEffect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trialsPDGF-induced proliferation of smooth muscular cells is related to the regulation of CREB phosphorylation and Nur77 expressionPPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.Role of G protein-coupled receptor kinase-2 in peroxisome proliferator-activated receptor gamma-mediated modulation of blood pressure and renal vascular reactivity in SHR.15-Deoxy-Delta-Prostaglandin J(2) Upregulates the Expression of LPS-Induced IL-8/CXCL8 mRNA in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertensionStatin therapy is not associated with improved vascular access outcomes.Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.PPAR-gamma effects on the vasculature.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasiaCoronary microvascular dysfunction in diabetes mellitus: A reviewTranscription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophilsPeroxisome proliferator-activated receptor gamma and atherosclerosis.Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetesVasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitroAntioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARgamma gene.Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations.ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis.Vascular effects of GI262570X (PPAR-gamma agonist) in the brown adipose tissue of Han Wistar rats: a review of 1-month, 13-week, 27-week and 2-year oral toxicity studies.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entryEndothelium-mediated control of vascular tone: COX-1 and COX-2 products.Atherogenic ω-6 Lipids Modulate PPAR- EGR-1 Crosstalk in Vascular Cells.Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
P2860
Q24642728-CD2A6C32-3CB0-4F94-97EF-BC4761137E12Q24677863-8ADCEF13-6E7C-44BD-8A0D-21537B231044Q24803245-3A3A7A3F-A6E9-406B-8792-221DC91A0BAAQ24814458-68D90B18-AA02-4991-9756-BD5F4DCD2969Q26862515-FB16F618-8D3C-4463-BED6-5AFB279F0E9FQ26863678-B3280F8C-6397-4807-9C44-BD13F163C030Q27024799-7403B947-673E-4912-ADB9-DECBED887568Q27309387-16CB8405-E961-459C-9EC3-50AAF6B58F4AQ28195413-87E17BC5-48CE-46DD-A2F5-3E2DDB6C0AF4Q28543544-681AB9ED-10CD-471D-81D6-22D954F48B2CQ28575756-A5796985-3C59-44AB-9EC3-4EE27336F94DQ28578260-3BF0CD91-D637-4BB4-AC51-780FF7F0A45FQ30444156-8F8B0C21-344F-4E75-9530-F77732CAB2F5Q33440398-09CF6FC3-475D-45F5-897D-26010FE7ABCCQ33578102-30ADCA26-EF6E-45D8-B1B1-BC452B268DEFQ33585657-81787AF1-6990-470C-B1E9-9D128B27D2D2Q33642053-BDA827B2-B137-4B3E-863C-A47BFD0C5485Q33810041-D4BE4A44-6403-4CB2-A27E-69DFF1C4DEF7Q34075472-AF81540B-FEE7-40EF-B964-00BF81A3D6B3Q34107495-DDA446CE-94E4-4882-8AFE-B148C2DE8954Q34161049-E979EDB5-2F20-41BF-8E22-1CD9309D3B24Q34178976-8421C5FB-4C08-49AA-9FB8-E409B1E48FADQ34277079-B1FC02F0-5031-4E1C-8308-C68AE354F8C8Q34290988-8A5664CF-C8F8-4DD2-A665-659B605A549DQ34299000-15896899-35BB-4477-95B5-D36417304597Q34312164-0A8B8BEB-5B24-45A4-A829-4CE0A296B8F1Q34427072-38E679C7-3842-4BE5-A187-359DCFAD8F9FQ34463399-7C00C43B-9BC0-47C3-8988-0E3CB9A492CFQ34492831-C1352D82-FB4A-496D-8382-56EDF7198E90Q34509903-5C0702C1-8EBB-48F9-951A-C3E19EA4E9A5Q34576530-80DFED07-1CBB-4E75-BA9F-3B4C506439B7Q34584762-28B7CBE7-C16A-4603-A82B-C4E6BC064051Q34605309-E93877B4-74A7-4D0D-978A-94B2A3EE3343Q34662862-F5DB8F01-2FA7-44CA-8ED5-6D41576C0DF7Q34790065-C7ACB3F3-812F-4723-A6D8-421105D0C4FCQ34897476-8995162A-325B-495B-8FB8-00E740F6EAD2Q35102314-D86D0666-9ABA-41FF-9BC5-E8F377AE8536Q35376020-83EDFC81-8E93-46D9-A084-930CC47FC4E3Q35495395-532603D3-CC50-4F75-B53E-7ABE93943842Q35588998-EB736DE2-230A-499E-9743-F273C7A4F593
P2860
Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
@en
type
label
Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
@en
prefLabel
Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
@en
P2093
P1433
P1476
Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
@en
P2093
Fishbein MC
P304
P356
10.1161/01.CIR.101.11.1311
P407
P577
2000-03-01T00:00:00Z